Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term aripiprazole administration in children and adolescents with autistic disorder
jRCT2080221820Phase 3
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of aripiprazole in Autism Spectrum Disorder (ASD), sponsored by Otsuka Pharmaceutical Co., Ltd.
02
Drugs
aripiprazole
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on jRCT2080221820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221820.